Regulation of de novo and salvage pathways in chemotherapy
- 1 January 1991
- journal article
- review article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 31, 45-67
- https://doi.org/10.1016/0065-2571(91)90008-a
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Azidothymidine Inhibition of Thymidine Kinase and Synergistic Cytotoxicity with Methotrexate and 5-Fluorouracil in Rat Hepatoma and Human Colon Cancer CellsCancer Communications, 1990
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Enhancement of 5-fluorouracil's anticancer activity by dipyridamolePharmacology & Therapeutics, 1989
- Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemiaAdvances in Enzyme Regulation, 1988
- Effects of 2′,3′‐dideoxynucleosides on mammalian cells and virusesJournal of Cellular Physiology, 1984
- Increased concentration of thymidine kinase in rat hepatomasBiochemical and Biophysical Research Communications, 1983
- Multi-enzyme-targeted chemotherapy by acivicin and actinomycinAdvances in Enzyme Regulation, 1982
- Guanosine-5′-phosphate synthetase and guanosine-5′-phosphate kinase in rat hepatomas and kidney tumorsBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- Key enzymes of IMP metabolism: Transformation- and proliferation-linked alterations in gene expressionAdvances in Enzyme Regulation, 1976
- IMP dehydrogenase, an enzyme linked with proliferation and malignancyNature, 1975